ICR Consilium news
20 February 2023
Consilium Strategic Communications expands international presence in US and Europe with two Senior Strategic Advisor appointments
Arne Naeveke, PhD joins Consilium to expand US Communications capabilities
Investor Relations presence in Europe strengthened with addition of Alexandra Deschner
London, 20 February 2023, Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, is pleased to announce the appointments of Arne Naeveke, PhD and Alexandra Deschner as Senior Strategic Advisors with effect from 1 March. Arne will head Consilium’s US communications offering, while Alexandra’s appointment will provide greater access to the investment community and best practice investor relations in Europe.
Arne brings more than 20 years of experience in the global biotech and biopharma industries as a trusted communications, advocacy and policy leader. Experienced across the entire value chain, from discovery through commercialisation and within a wide range of therapeutic modalities and disease areas, Arne combines his strong scientific background with strategic storytelling. His appointment further strengthen Consilium’s US communications capability.
Prior to joining Consilium, Arne served as Head of Corporate Communications, Vice President at Freeline Therapeutics, Inc where he delivered the communications strategy to enhance investor trust while leading all strategic communications development for the company. His experience also includes roles with Alexion Pharmaceuticals Inc (today AstraZeneca), the International AIDS Vaccine Initiative, GSK, Sanofi Pasteur MSD and Aventis (today Sanofi). Previously, Arne was a journalist for top-tier national print and broadcast media outlets in Germany. Arne has spent half of his career in Europe and the other half in the US. He is fluent in English, French and German and he holds a PhD in Biochemistry.
Alexandra brings more than 20 years of international, cross-sectoral experience. Her deep European investor relations (IR) experience adds to the strong roster of IR expertise at Consilium. She joins the firm from the Belgian life sciences company Univercells SA, where she served as Vice President, Investor Relations, and developed and implemented Univercells’ first IR strategy in preparation for a public listing. Prior to Univercells, Alexandra headed IR at Mithra Pharmaceuticals (MITRA.BR). Earlier IR positions were held at UCB (UCB.BR) and Fiat (FCA.MI). Alexandra is a native English and German speaker with fluency in French and Italian, and she holds an MBA in International Management from Fordham University in New York.
“We are continuing to grow our specialist offering and to globalise our expertise for clients in the US and Europe. Based in Boston, Arne joins us to head up our US communications offering, bolstering our strong network in the US. He brings a senior and flexible approach to Consilium for current and new clients. Alexandra will be based in Europe to provide a local hub and her bespoke IR expertise for our many clients who need access to European capital. I am very excited by these two new hires as we continue to build out our team and enhance our global offering and look forward to working closely with them."
Founder & Managing Partner of Consilium Strategic Communications
"It is an honour to be joining Consilium, a global leader in strategic healthcare communications and investor relations. I look forward to helping grow the firm’s communications capabilities in the US, and I am eager to begin working on behalf of Consilium’s clients to bring about innovation in healthcare and better serve patients and communities throughout the world.”
Arne Naeveke, PhD
Arne Naeveke, PhD, newly appointed Senior Strategic Advisor of Consilium Strategic Communications
"Consilium is already known as a global leader in investor relations in the healthcare space, and I enjoyed working with them whilst I was at Mithra, so it is with great pride that I join the team as a Senior Strategic Advisor based in Europe. I look forward to working with companies to increase their visibility in the capital markets, and I relish the opportunity to help expand Consilium’s European IR presence in the coming years.”
Alexandra Deschner, newly appointed Senior Strategic Advisor of Consilium Strategic Communications
For more information, please contact:
Consilium Strategic Communications
Mary-Jane Elliott/Amber Fennell
Tel: +44(0)20 3709 5700
Follow us: @consiliumhc
About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in financial and corporate communications and investor relations focused on the healthcare sector. Consilium's team, based in Europe and the US, provides strategic, long-term PR and IR advice to healthcare companies, Boards, senior decision-makers and executives on critical communications programmes, international media management, transactions and healthcare stakeholder challenges. Consilium has established deep knowledge and expertise across all areas of the global healthcare sector through broad involvement in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to discrete specialist reputation management projects.
For more information, please see www.consilium-comms.com